Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib vs Indomethacin in Acute Gout
NCT00142558Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2005
- Primary completion
- May 2005
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of etoricoxib in gout (2 arms), sponsored by Organon & Co. Primary endpoint: Patient assessment of pain. Started Jan 2005; status: completed.
02
Drugs
etoricoxib
03
Conditions
gout
Beyond the preview
Go deeper on NCT00142558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142558.